One more thing to look forward in the 2nd Q is the unveiling of the secret product which according to the last announcement will be tested soon:
"The Company completed formulation work on BTX 1801, a new pipeline product that has not been announced as yet, with pre‐clinical testing expected to commence in 2Q CY2018."
One more thing to look forward in the 2nd Q is the unveiling of...
Add to My Watchlist
What is My Watchlist?
